| Line Item | 2026-01-31 | Y/Y |
|---|---|---|
| Revenue | $709.0M | +31.7% |
| Cost of Revenue | $226.3M | +18.9% |
| Gross Profit | $482.7M | +38.7% |
| R&D Expense | $509.0M | +100.3% |
| SG&A Expense | $232.5M | +238.8% |
| Operating Income | -$652.6M | -155.2% |
| Pre-tax Income | -$668.1M | -90.7% |
| Income Tax | $11.3M | +167.1% |
| Net Income | -$679.4M | -91.6% |
| EPS (Basic) | -$3.18 | +12.6% |
| EPS (Diluted) | -$3.18 | +12.6% |
| Line Item | 2026-01-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $432.6M | +160.6% |
| Short-term Investments | $725.6M | +799.4% |
| Accounts Receivable | $158.3M | -18.9% |
| Inventory | $4.9M | -14.9% |
| Current Assets | $1.45B | +174.2% |
| Total Assets | $1.77B | +106.4% |
| Current Liabilities | $681.5M | +29.4% |
| Total Liabilities |
| Line Item | 2026-01-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $38.1M | +134.4% |
| Capital Expenditures | $22.9M | -32.0% |
| Investing Cash Flow | -$666.9M | — |
| Financing Cash Flow | $895.4M | +715.0% |
| Free Cash Flow | $15.2M | +110.5% |
| $1.58B |
| +17.4% |
| Stockholders' Equity | $194.5M | +140.1% |